Connect to other sites within the UBM Medica Network
In a recent study, researchers found that certain amino acids in the blood were associated with a twofold increased risk of a pancreatic cancer diagnosis.
Tarextumab Gets FDA Orphan Drug Designation for Lung, Pancreatic Cancer
The US Food and Drug Administration has granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and small-cell lung cancer.
NAPOLI-1: MM-398 Combo Shows Benefit in Metastatic Pancreatic Cancer
Combining MM-398 with 5-FU/leucovorin chemotherapy in metastatic pancreatic cancer patients resulted in improved survival compared with 5-FU/leucovorin alone.
FDA Approves Lanreotide Injection for GEP-NETs
The US Food and Drug Administration approved lanreotide for the treatment of patients with gastroenteropancreatic neuroendocrine tumors.
Long-Term Diabetes Shortens Pancreatic Cancer Survival
Pancreatic cancer patients with long-standing diabetes have poorer survival than those without diabetes, according to an analysis of a pair of studies.
Initial Treatment of Well-Differentiated Neuroendocrine Tumors
In patients with advanced, unresectable NETs, there are several treatment options; which of these may be considered depends on the site of origin of the tumor.
Health-Related QoL Poor Among Myeloma, Pancreatic Cancer Survivors
Survivors of multiple myeloma and pancreatic cancer may have some of the poorest physical health-related quality of life outcomes, according to a new study.
Study Describes Characteristics of Familial Pancreatic Cancer
About 9% of pancreatic cancer cases appear to be familial, and the risk of cancer in relatives of these patients does not appear limited to the pancreas.
By clicking Accept, you agree to become a member of the UBM Medica Community.